Beginning in 2010, it became practical to sequence whole genomes extracted from DNA extracted from ancient human bones, and to analyze the data to understand changes in biology over time. Since then, the amount of ancient DNA data has increased at an extraordinary rate, with the number of samples with at least one-fold genome coverage being five in 2013, 18 in 2014, and 116 in 2015. Dr. Reich will begin his lecture by describing how present-day Europeans derive from a fusion highly divergent ancestral populations as different from each other as are Europeans and East Asians.
It is now well established that the immune system can control and eliminate cancer cells. Adoptive T-cell transfer has the potential to overcome the significant limitations associated with vaccine-based strategies in patients who are often immune compromised. Dr. June will discuss how the emerging discipline of synthetic biology—which combines elements of genetic engineering and molecular biology to create new biological structures with enhanced functionalities—can be applied to cancer.
Elizabeth Ofili, M.D., M.P.H., F.A.C.C. Morehouse School of Medicine
Lack of inclusion of under represented populations in biomedical research contribute to inequities in health. The NIH Precision Medicine Initiative intends to build bridges from genome medicine to data science by reaching over 1 million Americans. It is not certain that under represented populations will actively engage PMI and other NIH discovery science opportunities. This persistent lack of participation will likely exacerbate health disparities even in this new age of genome science and digital technology.
For the past three decades, Thomas V. O’Halloran has investigated how fluctuations in the amount of metal ions inside cells influence key cellular decisions. Using genetic, chemical, structural, and mechanistic approaches, he has uncovered new types of metal receptors and tied their function to a number of disease-related physiological processes. O’Halloran identified early examples of metal ion receptors called metalloregulatory proteins that regulate gene expression.
Dr. Ronald Falk is internationally recognized physician-scientist whose lifelong career has been the study of autoimmune kidney disease and ANCA vasculitis. For over three decades, his research has led to a deeper understanding of the causes and conditions that may lead to the development of ANCA vasculitis in an effort to improve the lives of those patients afflicted with vasculitis and autoimmune kidney diseases.
Dr. Glimcher is President and CEO of Dana-Farber Cancer Institute, Principal Investigator and Director of Dana-Farber/Harvard Cancer Center and the proposed Richard and Susan Smith Professor of Medicine at Harvard Medical School. Previously, she was the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medical College in New York City, and Provost for Medical Affairs of Cornell University. Prior to her work at Cornell, Dr.
Xuetao Cao, M.D., Ph.D. Chinese Academy of Medical Sciences
Dr. Xuetao Cao is the current President of Chinese Academy of Medical Sciences and Peking Union Medical College.
Dr. Cao’s laboratory focuses on the understanding of innate signaling in immunity and inflammation, identification of cell subsets and new molecules in dendritic cell (DC)-initiated immune response and cancer immunotherapy. His group has identified important mediators and regulators of innate signaling, characterized immune subsets with regulatory function in immunity, inflammation and cancer.
Cisca Wijmenga, Ph.D. University Medical Center Groningen
Cisca Wijmenga has a long standing interest in understanding the molecular basis of the host immune system and how genetic variation leads to dysregulation of a proper immune response. She is particular interested in diseases associated such an imbalance, in particular celiac disease (a common autoimmune disorder) and candidiasis (a common infectious agent causing sepsis). Her research group focusing on the regulatory networks of immune cells and their perturbation by genetic variation or physiological stressors like infectious agents or dietary gluten.
Understanding which genes affect behavior, and how the resultant proteins work in the brain, remains a major challenge in biology. To address this goal, we are capitalizing on natural variation in behavior within and between species of wild mice. In this talk, Dr. Hoekstra will focus on an innate behavior, burrowing, which produces an intriguing and complex animal architecture. Dr. Hoekstra will present data from both he lab and the field that allow us a first glimpse into the genetics and neurobiology of behavioral evolution.
NIH has the honor of hosting world-renowned cellist Mr. Yo-Yo Ma for the Annual J. Edward Rall Cultural Lecture. The presentation will be in interview format between Mr. Ma and NIH Director Dr. Francis Collins speaking about the commonalities between music and science. During the event, Mr. Ma will answer questions from the NIH staff. The annual cultural lecture (part of the Wednesday Afternoon Lecture Series) honors the memory of J. Edward Rall, founder of the Clinical Endocrinology Branch (now within NIDDK), and the first Deputy Director for Intramural Research.
This page was last updated on Tuesday, August 10, 2021